BriaCell Therapeutics tumbles 10% during regular trading on melanoma vaccine milestoneUS Stock Market Update·Aug 24 at 03:43 PMBCTX+0.14%
BriaCell Therapeutics plunges 13% on melanoma vaccine milestoneUS Stock Market Update·Aug 24 at 01:46 PMBCTX+0.14%
BriaCell says Bria-MEL+ melanoma vaccine candidate hits genetic engineering milestonePUBT·Aug 24 at 11:30 AMBCTXZ-2.37%BCTX+0.14%
BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™ | BCTX Stock NewsStockTitan·Aug 24 at 03:30 AMBCTX+0.14%BCTXW0.00%
BriaCell wins FDA clearance to start Bria-PROS+ prostate cancer trialPUBT·Aug 5 at 11:30 AMBCTXW0.00%BCTX+0.14%
BriaCell publishes investor presentation on Bria-IMT immunotherapy program for metastatic breast cancerPUBT·Jul 21 at 03:28 PMBCTXW0.00%BCTXZ-2.37%
Is CRA International (CRAI) Quietly Redefining Its Oncology Consulting Edge With The Bria-IMT Mandate?Simplywall·Jul 16 at 05:08 PMCRAI-0.70%BCTXW0.00%
BriaCell opens first Canadian Phase 3 trial site at Sunnybrook’s Odette Cancer Centre in TorontoPUBT·Jul 16 at 11:31 AMBCTX+0.14%BCTXW0.00%
BriaCell signs manufacturing deal with FUJIFILM Biotechnologies for Bria-IMT Phase 3 supplyPUBT·Jul 15 at 11:30 AMBCTX+0.14%BCTXW0.00%
BriaCell subsidiary BriaPro reports $1.32M assets, $299,950 cash after sCD80 license acquisitionTradingView·Jun 26 at 08:13 PMBCTXZ-2.37%BCTX+0.14%
